90 related articles for article (PubMed ID: 7702632)
1. High-affinity binding sites for neuroleptic drugs in human peripheral blood lymphocytes and their relation to dopamine receptors. A long-standing controversy.
Vile JM; Strange PG
Biochem Pharmacol; 1995 Mar; 49(6):747-53. PubMed ID: 7702632
[No Abstract] [Full Text] [Related]
2. [Kinetic characteristics of neuroleptic binding sites on human lymphocytes].
Izumrudova II; Zaĭtsev SV; Koshkin AA; Porodenko NV; Varfolomeev SD
Bioorg Khim; 1990 Feb; 16(2):272-4. PubMed ID: 1971512
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptors, neuroleptics, and schizophrenia.
Snyder SH
Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity to neuroleptic drugs of cerebral dopamine receptors following chronic treatment of rats with trifluoperazine.
Dawbarn D; Pycock C
Eur J Pharmacol; 1981 May; 71(2-3):233-45. PubMed ID: 6113967
[No Abstract] [Full Text] [Related]
5. Increased renal neuroleptic binding in spontaneously hypertensive rats.
Rosenblatt JE; Shore D; Wyatt RJ; Pert CB
Eur J Pharmacol; 1980 Oct; 67(2-3):317-20. PubMed ID: 6109638
[TBL] [Abstract][Full Text] [Related]
6. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
Marshall AM; Mishra RK
Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
[No Abstract] [Full Text] [Related]
7. [Relation between brain D2-dopamine receptors and 3H-spiperone binding sites of intact lymphocytes].
Noguchi-kuno SA; Nakata C; Nishitani H
Rinsho Shinkeigaku; 1983 Sep; 23(9):814-8. PubMed ID: 6232031
[No Abstract] [Full Text] [Related]
8. Binding of 3H-spiperone to human peripheral lymphocytes: absence of stereospecific high-affinity binding.
Feenstra A; Coggiano MA; Wyatt RJ
Psychiatry Res; 1989 Dec; 30(3):259-64. PubMed ID: 2482515
[TBL] [Abstract][Full Text] [Related]
9. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro].
Oelssner W; Peinhardt G; Büge A
Pharmazie; 1985 May; 40(5):341-2. PubMed ID: 2863832
[TBL] [Abstract][Full Text] [Related]
10. Abnormal neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
[TBL] [Abstract][Full Text] [Related]
11. Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors.
Bylund DB
J Pharmacol Exp Ther; 1981 Apr; 217(1):81-6. PubMed ID: 6110776
[TBL] [Abstract][Full Text] [Related]
12. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
Spano PF; Memo M; Govoni S; Trabucchi M
Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
[No Abstract] [Full Text] [Related]
13. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptor binding of a novel dibenzodioxazocine derivative, EGYT-2509.
Gyüre K; Szentendrei T; Kanyicska B; Fekete MI; Rónai AZ
Pol J Pharmacol Pharm; 1985; 37(3):253-61. PubMed ID: 2866498
[TBL] [Abstract][Full Text] [Related]
15. A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone.
Hartley EJ; Spuhler K; Prasad KN; Seeman P
Brain Res; 1980 May; 190(2):574-7. PubMed ID: 6154511
[No Abstract] [Full Text] [Related]
16. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
Tachizawa H; Sudo K; Sano M
Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256
[TBL] [Abstract][Full Text] [Related]
17. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
[TBL] [Abstract][Full Text] [Related]
18. A radioreceptor assay for neuroleptic drugs in plasma.
Lader SR
J Immunoassay; 1980; 1(1):57-75. PubMed ID: 6112242
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic/dopamine receptors: elevation and reversal.
List S; Seeman P
Adv Biochem Psychopharmacol; 1980; 24():95-101. PubMed ID: 6105811
[No Abstract] [Full Text] [Related]
20. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
Florijn WJ; Tarazi FI; Creese I
J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
